You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Correction: Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma

Article Text

Article menu

See original article:

Download PDFPDF

XML
Correction
Correction: Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma

https://doi.org/10.1136/jitc-2020-000590corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Goldberg JL, Navid F, Hank JA, et al. Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma. J ImmunoTherapy Cancer 2020;8:e000590. doi: 10.1136/jitc-2020-000590

    Since the online publication of this article, the author names ‘Jacquelyn A Hank’ and ‘Stephen D Gillies’ were spelt incorrectly as ‘Jacqueline A Hank’ and ‘Steven D Gillies’. This has now been corrected.